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Introduction
Overt hypothyroidism affects between 4 and 10% of the world population [1] . Thyroid hormones regulate energy metabolism and affect the tissue response of other hormones in the organism [2, 3] . Changes in the levels of thyroid hormones may affect muscle and visceral fat tissue mass, and may be involved in the pathogenesis of insulin resistance, type 2 diabetes mellitus and cardiovascular events [4] . TSH affects the function of the TSH receptor (TSHR) protein and stimulates adipokine production in abdominal adipose tissue and preadipocytes in humans [5] . Despite the important effects of thyroid hormones on intermediate metabolism and energy homeostasis, its relationship with cytokines secreted from adipose tissue is still unclear [6] . Betatrophin, also known as ANGPLT-8, is a 188 amino acid and 22 kDa glycoprotein produced in the liver and adipose tissue [7, 8] . Betatrophin inhibits LPL, one of the key enzymes for lipid metabolism [9] . LPL is the enzyme that catalyzes the breakdown of triglycerides to free fatty acids [10] . LPL hyperactivity was associated with decreased plasma TG levels and decreased cardiovascular risks, whereas LPL function loss was associated with hypertriglyceridemia and increased cardiovascular risk [10, 11] . Serum betatrophin levels and triglyceride levels were positively correlated in previous studies [8, 12] .
Betatrophin, unlike the other members of the ANGPTL family, does not carry the fibrinogen-like region, coiled spiral area and disulfide bond [13] . Therefore, betatrophin is considered as an atypical member in the ANGPTL family and a newly emerged player in lipid metabolism [9, 14] .
There are recent studies investigating the effects of betatrophin on beta-cell expansion and islet function [15] . In this study, we tried to explain the relationship between hypothyroidism and fat metabolism by serum betatrophin levels. This study may help demonstrate the effects of hypothyroidism on adipose tissue.
Materials and methods
Design and patients 44 patients between the ages 20 and 69, who were diagnosed with overt hypothyroidism in Internal Medicine Department between September 2017 and February 2018 and 40 healthy volunteers were included in this study.
In our study, TSH> 4.94 mIU / L, FT4 <9.01 ng / dL and / or freeT3 <2.5 pg / mL were defined as overt hypothyroidism. Patients with diabetes mellitus, acute and chronic renal failure, hypertension, coronary heart disease, congestive heart failure, peripheral arterial disease, cerebrovascular accident, malignancy, acute and chronic liver diseases, pituitary gland and hypothalamus diseases, major operation history in the last three months, rheumatic diseases, severe psychiatric conditions, malabsorption syndrome, pregnancy, alcohol intake and smoking were excluded. Blood was obtained from all participants for routine laboratory tests including fasting glucose, urea, creatinine, AST, ALT, TSH, free T3, free T4, TPO-Ab, TG-Ab, HDL-cholesterol, LDLcholesterol, triglyceride, and total cholesterol levels. Routine laboratory tests were performed using Cobas Elecsys 601 (Roche Diagnostics, Switzerland). An additional tube of blood was obtained from the volunteers for the measurement of serum betatrophin levels. Blood tubes rested at room temperature for 30 minutes, then centrifuged at 4000 rpm for 10 min. The resulting sera were stored at -80 ° C.
BMI was obtained by dividing the patient's weight in kg by the square of height in meters. Insulin resistance was calculated by HOMA-IR index: Fasting serum insulin (uIU / mL) * Fasting serum glucose (mg / dL) / 405. Patients with HOMA-IR index> 2.5 were accepted as insulin resistance.
Measurements of betatrophin
Human ANGPTL-8 (betatrophin) levels were measured by using an enzyme-linked immunosorbent assay. Performance characteristics of betatrophin assay were as folows: The analytical (linear) measurement range was 11.4-1200 ng / mL and the minimum detection limit was 10.2 ng / mL. The reported intraassay and interassay CV's were 8.5% and 7.7%, respectively.
Ethical committee approval Our study was approved by the Committee of Ethics Committee of Okmeydanı Training and Research Hospital of Health Sciences University and it was complied with the principles of Helsinki Declaration (date: 19.12.2017 ; no: 784).
Statistical analysis IBM SPSS version 25.0 (SPSS Inc, Chicago Illinois) statistical program was used. The distribution of variables was measured by Kolmogorov-Smirnov test. The data were expressed as mean (standard deviations, SD) for normally distributed variables and % frequencies for non-normally distributed and categorical variables. In the comparison of parametric data between two independent groups, independent sample t-test was performed. Mann-Whitney U test was used for the analysis of non-normally distributed data. The correlation of betatrophin, a non-normally distributed variable, to other parameters was analyzed by non-parametric Spearman test.
Multivariate regression analysis and stepwise option were used to evaluate all independent variables with serum betatrophin as the dependent variable. As a result of the regression analysis, independent variables other than TSH and triglyceride were excluded, because they were not related to serum betatrophin levels. All calculated P-values were bidirectional and P-values <0.05 were considered statistically significant.
Results
The demographic and laboratory data of study groups are summarized in table 1.
When compared with healthy controls, TSH, anti TPO, anti TG, serum triglyceride and serum betatrophin levels significantly increased in patients with hypothyroidism, while free T4 and free T3 decreased. Age, sex, BMI, Fast glucose, HOMA-IR, AST, ALT, urea, creatinine, HDL cholesterol, LDLcholesterol and total cholesterol levels were not different.
The results of the correlation analysis between serum betatrophin levels and other parameters are summarized in table 2 and figure 1. There was a positive correlation between betatrophin levels of all participants and TSH, TG and total cholesterol levels. A negative correlation was found between P a g e / S a y f a | 633 betatrophin levels of all participants and free T3, free T4 and HDL-cholesterol levels.
Multivariate regression analysis results are presented in table 3. Comparison of Anti-TPO> 9 and Anti-TPO <9 patients using the Mann-Whitney-U test is presented in table 4. 
Discussion
Thyroid hormones govern energy metabolism by activating glucose, fat and protein oxidation in tissues. In hypothyroidism, decreased T3 and T4 levels and increased TSH levels are characteristic. With the decrease in thyroid hormones, instead of being oxidized for energy, lipids are stored in the body. Consequently, body weight increases and lipid profile changes [16, 17] .
As is known, visceral adipose tissue is the main adipose tissue producing various adipokines. Numerous evidences have shown that cytokines secreted from adipose tissue lead to endothelial dysfunction and cause atherosclerosis with dyslipidemic effects [18] [19] [20] [21] . In a study, visceral adipose tissue volume was increased in patients with hypothyroidism [22] . Despite the intense interaction of thyroid hormones and regulatory hormones secreted from adipose tissue, this relationship has not been fully elucidated. In our study, we investigated the level of ANGPTL family cytokines secreted from adipose tissue in patients diagnosed with overt hypothyroidism and found it was closely related to lipid metabolism, in accordance with the previous studies.
ANGPTL-8, also known as betatrophin, is a regulator and stabilizer in lipid metabolism by its LPL inhibition, which is also a feature of other cytokines in the ANGPTL family [23, 24] . As is known, LPL provides clearance of TG-rich plasma lipoproteins [25] . LPL is located in the capillary endothelium and catalyzes the hydrolysis of endogenous VLDL-TG and exogenous chylomicron-TG to glycerol and FFAs [26] .
A few studies in the literature demonstrate the relationship between hypothyroidism and serum betatrophin levels. In one study, the relationship between betatrophin levels and subclinical and overt hypothyroidism was investigated and serum betatrophin levels were found to be increased in hypothyroidism [27] . The same study suggested that betatrophin was a metabolic regulator that may affect lipid and glucose metabolism. However, it was stated that serum betatrophin elevation may be associated with thyroid autoimmunity. In our study, we also found that serum betatrophin levels were higher in patients diagnosed with overt hypothyroidism compared to the control group. Regardless of autoimmunity, we believe that betatrophin plays a regulator role in fat metabolism by its inhibitory effect of LPL, due to the fact that serum betatrophin levels were similar in patients with hypothyroidism having high or normal anti-TPO values.
In our study, although there were similar features regarding BMI, fasting plasma glucose and HOMA-IR levels in patients with hypothyroidism and control group, triglyceride levels were significantly different between both groups.
The relationship between betatrophin levels and TG levels could be detected even in patients with subclinical hypothyroidism, suggesting that hypertriglyceridemia in hypothyroidism may be mediated by increased betatrophin release [27] . In our study, there was a strong positive correlation between TG and betatrophin levels. The elevated betatrophin level inhibits LPL and prevents the breakdown of triglycerides into free fatty acids and glycerol. In hypothyroidism, lipid oxidation for energy production decreases as a result of the decrease of fatty acid. On the other hand, elevated TG in the serum may initiate triggering mechanisms for obesity, insulin resistance and cardiovascular events, and especially for hepatosteatosis.
In a study in which we investigated the relationship between ANGPTL-4 and hepatosteatosis, we found that LPL inhibition further induces hepatosteatosis by causing TG accumulation in the tissues [14] . Betatrophin is known to exhibit the main characteristics of the ANGPTL family, with some structural differences. Stress, insulin resistance, inflammation and thermogenesis may affect betatrophin expression and signaling pathways [28] . The contradictory results in the previous studies suggest that betatrophin may be a multidimensional adipokine that can function differently under changing conditions. Limitation The small number of patients was the most important limitation for our study. Further studies are needed with more patient groups.
Conclusion
In our study, we found that serum betatrophin levels were high in hypothyroid patients. Consequently, considering the relationship between betatrophin and TG levels, it may give promising results as a therapeutic target.
